Exercise or conversion by Simba Gill of 1171 shares of Evelo Biosciences subject to Rule 16b-3

EVLODelisted Stock  USD 8.23  2.68  24.56%   
About 61% of Evelo Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Evelo Biosciences pink sheet suggests that many investors are alarmed at this time. Evelo Biosciences' investing sentiment overview a quick insight into current market opportunities from investing in Evelo Biosciences. Many technical investors use Evelo Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Evelo Biosciences Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Read at macroaxis.com
Evelo insider trading alert for exercise of common stock by Simba Gill, President CEO, on 9th of August 2023. This event was filed by Evelo Biosciences Inc with SEC on 2023-08-09. Statement of changes in beneficial ownership - SEC Form 4

Evelo Biosciences Fundamental Analysis

We analyze Evelo Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evelo Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evelo Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

Evelo Biosciences is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Evelo Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Evelo Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Evelo Biosciences could also be used in its relative valuation, which is a method of valuing Evelo Biosciences by comparing valuation metrics with similar companies.

Peers

Evelo Biosciences Related Equities

SRZNSurrozen   19.37   
0%
100.0%
PCSAProcessa Pharmaceuticals   18.37   
0%
94.0%
CCCCC4 Therapeutics   8.59   
0%
44.0%
GBIOGeneration Bio   6.29   
0%
32.0%
ALRNAileron Therapeutics   4.38   
0%
22.0%
ABVCABVC Biopharma   3.92   
0%
20.0%
CTMXCytomX Therapeutics   3.92   
0%
20.0%
DRMADermata Therapeutics   2.73   
0%
14.0%
EWTXEdgewise Therapeutics   2.48   
0%
12.0%
ASMBAssembly Biosciences   1.25   
0%
6.0%
NUVBNuvation Bio   0.35   
0%
1.0%
TPSTTempest Therapeutics   1.04   
5.0%
0%
KRONKronos Bio   1.04   
5.0%
0%
ENSCEnsysce Biosciences   2.00   
10.0%
0%
ERASErasca   2.05   
10.0%
0%
TILInstil Bio   9.39   
48.0%
0%
WINTWindtree Therapeutics   13.11   
67.0%
0%
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Consideration for investing in Evelo Pink Sheet

If you are still planning to invest in Evelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evelo Biosciences' history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account